Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. Go to Publication You Might Also Like Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres August 30, 2019 Resection of a endobronchial hamartoma by electrocautery and argon plasma ablation via fiberoptic bronchoscopy. July 18, 2006 Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India. March 22, 2017 COVID-19 care in India: the course to self-reliance September 3, 2020 Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis September 3, 2020
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres August 30, 2019
Resection of a endobronchial hamartoma by electrocautery and argon plasma ablation via fiberoptic bronchoscopy. July 18, 2006
Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India. March 22, 2017
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis September 3, 2020